This pathway is frequently dysregulated in HNSCC due to various factors, including genetic mutations, amplifications, such as PIK3CA, loss of the tumor suppressor PTEN, and overexpression of EGFR. This evidence concerns the gene PTEN and head and neck squamous cell carcinoma.